CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Glaxosmithkline Capital Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Glaxosmithkline Capital Inc
1403 Foulk Rd Ste 106
Phone: (302) 479-5801p:302 479-5801 WILMINGTON, DE  19803-2788  United States Ticker: SBH SBH
This is a Subsidiary, click here for the Parent Company
Business Summary
GlaxoSmithKline Capital Inc. is a United States-based company. The Company is a wholly owned subsidiary of GlaxoSmithKline plc. The Company exists for the purpose of issuing debt securities, the proceeds of which will be invested by it in marketable securities or advanced to, or otherwise invested in, subsidiaries or affiliates of GlaxoSmithKline plc. The debt securities issued by the Company include debentures, notes, bonds, guarantees and other evidences of indebtedness. The debt securities issued by the Company will be guaranteed by GlaxoSmithKline plc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
----Yes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Director Jonathan W.Box 1/1/2022
Vice President, Director Richard J.Latchford

Business Names
Business Name
GLAXOSMITHKLINE CAPITAL INC
GlaxoSmithKline Capital Inc.
SBH

General Information
Federal Tax Id: 510332587
Fax Number: (302) 651-8422


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 4, 2024